We are live on ! Find out more
AKCA

Akcea Therapeutics Inc
AKCA

Delisted

AKCA was delisted on the 9th of October, 2020.

Back to rankings

45 hedge funds and large institutions have $480M invested in Akcea Therapeutics Inc in 2017 Q3 according to their latest regulatory filings, with 45 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
45
Holders Change
+45
Holders Change %
–
% of All Funds
1.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
45
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$162M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$59.7M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$19.9M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$17.7M
5
BlackRock
BlackRock
New York
+$15.5M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
RhumbLine Advisers
26
RhumbLine Advisers
Massachusetts
$353K +$236K +12,762 New
VF
27
Virtu Financial
New York
$329K +$220K +11,898 New
Manulife (Manufacturers Life Insurance)
28
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$308K +$206K +11,115 New
AAP
29
Ardsley Advisory Partners
Connecticut
$277K +$185K +10,000 New
CS
30
Credit Suisse
Switzerland
$277K +$186K +10,033 New
AIG
31
American International Group
New York
$275K +$184K +9,930 New
CSS
32
Cubist Systematic Strategies
Connecticut
$269K +$180K +9,728 New
Wells Fargo
33
Wells Fargo
California
$222K +$148K +8,007 New
NFA
34
Nationwide Fund Advisors
Ohio
$209K +$140K +7,552 New
TRCT
35
Tower Research Capital (TRC)
New York
$195K +$131K +7,054 New
Zurich Cantonal Bank
36
Zurich Cantonal Bank
Switzerland
$180K +$120K +6,500 New
SO
37
STRS Ohio
Ohio
$118K +$79.6K +4,300 New
Legal & General Group
38
Legal & General Group
United Kingdom
$111K +$73.6K +3,976 New
JP Morgan Chase
39
JP Morgan Chase
New York
$74K +$48.5K +2,619 New
Royal Bank of Canada
40
Royal Bank of Canada
Ontario, Canada
$39K +$26K +1,407 New
BNP Paribas Financial Markets
41
BNP Paribas Financial Markets
France
$24.7K +$16.5K +894 New
Barclays
42
Barclays
United Kingdom
$10K +$6.44K +348 New
UBS Group
43
UBS Group
Switzerland
$8K +$5.42K +293 New
SIM
44
Sonora Investment Management
Arizona
$1.38K +$926 +50 New
CTC
45
Central Trust Company
Missouri
$1K +$926 +50 New
1
2

AKCA Hedge Fund Activity: Q3 2017 in Review

45 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Akcea Therapeutics Inc (AKCA) for Q3 2017, worth a combined $480M.

Buyers outnumbered sellers: 45 funds opened new AKCA positions and 0 closed out — a net gain of 45 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $162M.

  • 45 institutional investors held Akcea Therapeutics Inc (AKCA) as of Q3 2017, up from 0 in Q2 2017.
  • Funds reported $480M of Akcea Therapeutics Inc stock for Q3 2017.
  • 45 funds opened new Akcea Therapeutics Inc positions in Q3 2017 and 0 closed out, a net change of +45 holders.
  • The largest Akcea Therapeutics Inc buyer in Q3 2017 was Fidelity Investments, an estimated $162M added.

Based on aggregated 13F filings for Q3 2017.